York U receives nearly $10 million from Wellcome to continue the fight against antimicrobial resistance

Skip to Content News Archives Economy Energy Oil & Gas Renewables Electric Vehicles Mining Commodities Agriculture Real Estate Mortgages Mortgage Rates Finance Banking Insurance Fintech Cryptocurrency Work Wealth Smart Money Wealth Management Investor Personal Finance Family Finance Retirement Taxes High Net Worth FP Comment Executive Women Puzzmo Newsletters Financial Times Business Essentials More Innovation Information Technology FP500 Podcasts Small Business Lives Told Tails Told Shopping Financial Post Store Obituaries Place a Notice Advertising Advertising With Us Advertising Solutions Postmedia Ad Manager Sponsorship Requests Classifieds Place a Classifieds ad Working Profile Settings My Subscriptions My Offers Newsletters Customer Service FAQ News Economy Energy Mining Real Estate Finance Work Wealth Investor FP Comment Executive Women Puzzmo Newsletters Financial Times Business Essentials This advertisement has not loaded yet, but your article continues below.HomeGlobeNewswireThis section is The content in this section is supplied by GlobeNewswire for the purposes of distributing press releases on behalf of its clients. Postmedia has not reviewed the content. by GlobeNewswire York U receives nearly $10 million from Wellcome to continue the fight against antimicrobial resistanceAuthor of the article:The Global Strategy Lab based at York University announced the launch of its strategic plan for it AMR (antimicrobial resistance) Policy Accelerator and $9.6M in funding from UK-based Wellcome. From left, David Peters, Dean of the Faculty of Health and the School of Medicine at York University; York Associate Professor Mathieu Poirier, Director of the Global Strategy Lab; Dr. Geneviève Boily-Larouche, AMR Policy Accelerator Managing Director; Maggie Chi, Parliamentary Secretary to the Minister of Health; Lisa Philipps, Interim President and Vice-Chancellor; Dr. John-Arne Røttingen, Wellcome CEO; Dr. Steven Hoffman, Founder, Global Strategy Lab and Dahdaleh Distinguished Chair in Global Governance and Legal Epidemiology GNWGlobal Strategy Lab’s AMR Policy Accelerator announces four-year strategic plan that will focus on global governance and national policiesTHIS CONTENT IS RESERVED FOR SUBSCRIBERS ONLYSubscribe now to read the latest news in your city and across Canada.Exclusive articles from Barbara Shecter, Joe O'Connor, Gabriel Friedman, and others.Daily content from Financial Times, the world's leading global business publication.Unlimited online access to read articles from Financial Post, National Post and 15 news sites across Canada with one account.National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.Daily puzzles, including the New York Times Crossword.SUBSCRIBE TO UNLOCK MORE ARTICLESSubscribe now to read the latest news in your city and across Canada.Exclusive articles from Barbara Shecter, Joe O'Connor, Gabriel Friedman and others.Daily content from Financial Times, the world's leading global business publication.Unlimited online access to read articles from Financial Post, National Post and 15 news sites across Canada with one account.National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.Daily puzzles, including the New York Times Crossword.REGISTER / SIGN IN TO UNLOCK MORE ARTICLESCreate an account or sign in to continue with your reading experience.Access articles from across Canada with one account.Share your thoughts and join the conversation in the comments.Enjoy additional articles per month.Get email updates from your favourite authors.THIS ARTICLE IS FREE TO READ REGISTER TO UNLOCK.Create an account or sign in to continue with your reading experience.Access articles from across Canada with one accountShare your thoughts and join the conversation in the commentsEnjoy additional articles per monthGet email updates from your favourite authorsSign In or Create an AccountToronto, Ontario, Sept. 24, 2026 (GLOBE NEWSWIRE) — In a global health environment where funding is increasingly tight, York University based Global Strategy Lab (GSL) is launching a four-year strategic plan for its initiative, the AMR Policy Accelerator to drive progress against antimicrobial resistance (AMR). Unveiled today by GSL Director Mathieu JP Poirier and Accelerator Managing Director, Geneviève Boily-Larouche, the plan is supported by $9.6 million (£5 million) from Wellcome – a leading global health philanthropy.“The threat of antimicrobial resistance is no less pressing today than when we launched the Accelerator in 2022, but we are determined to ensure that the recent adoption of a global scientific panel and action plan for AMR will mark a turning point in the global fight against this silent pandemic,” says Poirier, also an Associate Professor in the Faculty of Health at York. “We are proud that Wellcome has been with us since day one, and this renewal of funding signals the impact of our work and the significance of our strategic plan.”Get the latest headlines, breaking news and columns.By signing up you consent to receive the above newsletter from Postmedia Network Inc.A welcome email is on its way. If you don't see it, please check your junk folder.The next issue of Top Stories will soon be in your inbox.We encountered an issue signing you up. Please try againStarted with support from Wellcome, the Accelerator catalyzes scientific research and evidence-informed policy to support governments to act on the ongoing crisis of AMR.“There has been some important progress made against the growing threat of antimicrobial resistance in the past decade. However, many countries are still facing challenges to develop and deliver impactful, evidence-based national action plans due to the complex, multi-faceted nature of AMR. Global Strategy Lab’s work plays a vital role in supporting countries, particularly in the global south, to be better equipped to tackle AMR, including mobilisation of the international evidence panel,” says Jeremy Knox, Head of Infectious Disease Policy at Wellcome.To date, projects have included research to inform global governance mechanisms, the creation of practical policy tools to support implementation of national action plans on AMR and providing capacity strengthening activities to over 200 AMR policymakers, international organization staff and civil society partners in 75 countries.The work has also taken on a greater emphasis on making sure gender and equity provisions are in place when considering appropriate and effective AMR policies.“This investment is a powerful endorsement of the talent and ambition of our researchers,” says Lisa Philipps, Interim President and Vice-Chancellor of York University. “Antimicrobial resistance is one of the most urgent health threats of our time, and meeting it will take strong evidence, global collaboration and a real commitment to equity. The Global Strategy Lab brings all three. York is proud to be the home of this work, and grateful to Wellcome for backing it over the long term.”GSL announced today that from 2026-2030, the Accelerator’s work will focus on two connected priority areas:This advertisement has not loaded yet.This advertisement has not loaded yet, but your article continues below.Strengthening AMR global governance: Working with international organizations and global partners to support policy solutions and normative guidance that are grounded in evidence, equity, accountability, and a One Health approach. Championing evidence-informed national policy decisions: Working with national and regional partners to create practical tools that help translate research and global policy guidance into context-appropriate, sustainable, and feasible national-level actionAbout York UniversityYork is a modern, multi-campus, urban university located in Toronto, Ontario. Backed by a diverse group of students, faculty, staff, alumni and partners, we bring a uniquely global perspective to help solve societal challenges, drive positive change, and prepare our students for meaningful life and career paths. York’s Glendon Campus is home to Southern Ontario’s Centre of Excellence for French Language and Bilingual Postsecondary Education. York’s campus in Costa Rica offers students exceptional transnational learning opportunities and innovative programs, while at the Markham Campus, innovation, technology, entrepreneurship and industry collaboration are built into every program. York’s new School of Medicine, the first Canadian medical school to focus on community-based primary health-care education, will welcome its first cohort in September 2028 (subject to accreditation). York was recently named one of Canada’s Greenest Employers for the 14th consecutive year. Together, we can make things right for our communities, our planet, and our future.About WellcomeWellcome supports science to solve the urgent health challenges facing everyone. We support discovery research into life, health and wellbeing, and we’re taking on three worldwide health challenges: mental health, infectious disease and climate and health.Sandra McLean York University sandramc@yorku.ca Notice for the Postmedia NetworkThis website uses cookies to personalize your content (including ads), and allows us to analyze our traffic. Read more about cookies here. By continuing to use our site, you agree to our Terms of Use and Privacy Policy.